Regeneron Pharmaceuticals Income After Taxes 2010-2024 | REGN
Regeneron Pharmaceuticals income after taxes for the twelve months ending September 30, 2024 was $4.655B, a 16.62% increase year-over-year.
- Regeneron Pharmaceuticals annual income after taxes for 2023 was $3.954B, a 8.87% decline from 2022.
- Regeneron Pharmaceuticals annual income after taxes for 2022 was $4.338B, a 46.28% decline from 2021.
- Regeneron Pharmaceuticals annual income after taxes for 2021 was $8.075B, a 129.86% increase from 2020.